Totally Implantable Venous Access Ports (TIVAP) are specialized devices designed for long-term venous therapy, widely used in oncology and other groups requiring prolonged intravenous access. Since their introduction into routine clinical practice in China, they have significantly enhanced the safety and comfort of vascular access management. However, substantial challenges remain in TIVAP utilization as China lacks a unified regulatory framework and standardized full-lifecycle management protocols. Significant disparities also exist among medical institutions in terms of surgical techniques, complication management, and surveillance, leading to inconsistent outcomes and patient satisfaction. This narrative review presents a review of TIVAP clinical applications and maintenance, incorporating the latest evidence-based strategies for implantation and complication mitigation. The objective is to provide a comprehensive reference for optimizing clinical decision-making, minimizing adverse events, and improving patient quality of life.
Building similarity graph...
Analyzing shared references across papers
Loading...
Andong Yu
Soochow University
Ruochong Pang
Soochow University
Mingqing Zhang
Soochow University
Frontiers in Oncology
SHILAP Revista de lepidopterología
Soochow University
Second Affiliated Hospital of Soochow University
Building similarity graph...
Analyzing shared references across papers
Loading...
Yu et al. (Fri,) studied this question.
synapsesocial.com/papers/69f04d9f727298f751e71ecf — DOI: https://doi.org/10.3389/fonc.2026.1800754
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: